ArticlePDF Available

A Hair Growth-Promoting Effect of Chinese Black Tea Extract in Mice

Authors:

Abstract and Figures

Chinese black tea extract (CBTE) fermented with Aspergillus sp. significantly promoted hair growth after 2 weeks of topical application in shaved 6 week-old male C3H/He mice. The hair growth-promoting effect of CBTE was potentiated synergistically by capsaicin, which has no effect on hair growth by itself. CBTE displayed an affinity for estrogen receptor (ER)α, with an IC50 value of 74.8 µg/mL. This effect of CBTE might be mediated by the ERs, since a similar effect induced by orally administered soy isoflavone, a mixture of ERs ligands, has been reported to be synergistically potentiated by capsaicin.
No caption available
… 
Content may be subject to copyright.
A Hair Growth-Promoting Effect of Chinese Black Tea Extract in Mice
I-Ching HOU,
1;2;
y
Yasuyuki OI ,
1
Hiroyuki FUJITA,
1
Yoshihisa YANO,
2
Harukazu FUKAMI,
2
and Masaaki YOSHIKAWA
3
1
Research and Development Department, Nippon Supplement, Inc.,
Applause Tower 18 F, 19-19, Chayamachi, Kita-ku, Osaka 530-0013, Japan
2
Graduate School of Bioenvironmental Science, Kyoto Gakuen University,
1-1 Nanjyo-otani, Sogabe-cho, Kameoka, Kyoto 621-8555, Japan
3
Division of Functional Food Science, Research Institute for Production Development,
15 Shimogamo-morimoto-cho, Sakyo-ku, Kyoto 606-08 05, Japan
Received April 12, 2013; Accepted June 10, 2013; Online Publication, July 7, 2013
[doi:10.1271/bbb.130298]
Chinese black tea extract (CBTE) fermented with
Aspergillus sp. significantly promoted hair growth after 2
weeks of topical application in shaved 6 week-old male
C3H/He mice. The hair growth-promoting effect of
CBTE was potentiated synergistically by capsaicin, which
has no effect on hair growth by itself. CBTE displayed an
affinity for estrogen receptor (ER), with an IC
50
value
of 74.8 g/mL. This effect of CBTE might be mediated by
the ERs, since a similar effect induced by orally admin-
istered soy isoflavone, a mixture of ERs ligands, has been
reported to be synergistically potentiated by capsaicin.
Key words: hair growth; Chinese black tea extract
(CBTE); estrogen receptor; C3H/He mice;
capsaicin
Alopecia is a common problem. Although various hair
growth-promoting substances have been reported,
1–3)
we
sought an improved approach for people who continue
to have a problem with hair growth.
It is known that flavonoids, such as the green tea
ingredient ()-epigallocathechin gallate (EGCG), pro-
mote hair growth after oral administration
4,5)
but the hair
growth-promoting effect of teas by topical application
has rarely been reported, although this administration
route is helpful in limiting the hair growth to the desired
region. In this study, we investigate the effect of an
extract of the well known Chinese black tea, Pu-erh tea,
a traditional tea fermented with Aspergillus sp., on hair
growth in shaved male C3H/He mice, administered
topically.
It has been reported that capsaicin augments the hair
growth-promoting effect of soy isoflavone, an ER
agonist, by synergistically potentiating insulin-like
growth factor I (IGF-1) release via stim ulation of
calcitonin gene- related peptide (CGRP) release from
sensory nerve endi ngs, without showing any effect on
hair growth by itself.
6)
Hence we tested the effect of
capsaicin on the hair growth-promoting effect of CBTE
to gain insight into its mode of action.
CBTE was prepared as described previously.
7,8)
CBTE powder was mixed into a basal solvent containing
propylene glycol, EtOH, and distilled water at a ratio of
5:3:2, and this was centrifuged for 10 min at 9;800 g
to give 20% (w/w). The supernatant was used to prepare
the samples. Six-week old C3H/He male mice in
the telogen phase were purchased from Japan SLC
(Shizuoka, Japan). The mice were housed in plastic
cages (four mice per cage) in a room with controlled
temperature, air flow, and humidity under a 12-h light/
12-h dark cycle, and were fed ad libitum with MF pellets
(Oriental Yeast, Osaka, Japan). The care and handing of
the animals were in accordance with Notification no. 88
of the Ministry of Environment of Japan (2006) and the
Guidelines for the Proper Conduct of Animals Experi-
ments of Kyoto Gakuen University. Three days after
shaving, 150
mL of the sample solution was applied
topically to the backs of the mice daily for 2 weeks.
Changes in the dorsa l area of the mice were observed
and recorded by visual inspection and photography.
The ratio of the hair growth area was calculated by a
comparison of the hair growth and shaved areas, which
were measured by means of image analysis software.
Data were expressed as mean SD. Student’s t test was
used to determine statistical significance.
As shown in Fig. 1, the application of 3.5% CBTE
cause a significant increase after 2 weeks of topical
application (p < 0:05). As reported for the hair growth-
promoting effect of soy isoflavone, 0.05% capsaicin
synergistically potentiated CBTE, although the effect
was not significant. Even though an inhibitory effect
of capsaicin on hair-shaft elongation of human hair
follicles in vitro has been reported,
9)
no such effect was
observed in our in vivo system.
Next we investigated the affinities of CBTE for the
ER receptor, since its hair growth-pr omoting effect, as
well as that of soy isoflavone, acting as an ER agonist,
was potentiated by capsaicin, as described above. The
affinity of CBTE for the ER receptor was evaluated by
radioligand binding assays using human recombinant
ER receptor expressed in insect Sf9 cel ls, along with
0.5 n
M [
3
H]-estradiol. Non-specific binding was estimated
in the presence of 1 mM diethylstilbestrol, as previously
described.
10)
The IC
50
value was determined by non-
y
To whom correspondence should be addressed. Fax: +81-6-6376-2234; E-mail: hou@nippon-sapuri.co.jp
Abbreviations: CBTE, Chinese black tea extract; EGCG, ()-epigallocathechin gallate; ECG, epicatechin gallate; IGF-1, insulin-like growth factor
I; CGRP, calcitonin gene-related peptide
Biosci. Biotechnol. Biochem., 77 (7), 1606–1607, 2013
Communication
linear, least squares regression analysis using MathIQ
(ID Business Solutions, Guildford, UK).
CBTE displayed an affinity for ER,withanIC
50
value of 74.8 mg/mL, irrespective of whether it is
agonistic or anta gonistic. ERs have been reported to be
related to hair growth.
11–14)
ER ligands, such as
isoflavone, have been found to exert hair growth-
promoting effects in mice.
6)
These results suggest that
the hair growth-promoting effect of CBTE might also be
mediated by ERs. EGCG and epicatechin gallate (ECG)
have been reported to have affinities for ER,withIC
50
values of 480 mM and 550 mM respectively,
15)
but these
catechins were not detected in CBTE by high perform-
ance liquid chromatography (data not shown). There-
fore, active substances showing an affinity for the ERs
might be produced during the course of fermentation in
the course of CBTE production.
Isolation of the constituents in CBTE that are
essential for its hair growth-promoting and ER binding
activities is currently underway in our laboratory.
Investigation of the details of the mechanism of the
hair growth-promoting effect of CBTE awaits isolation
of the active substances.
Acknowledgments
Financial support was provided by Nippon Supple-
ment, Inc. There was no conflict of interest.
References
1) Oura H, Iino M, Nakazawa Y, Tajima M, Ideta R, Nakaya Y,
Arase S, and Kishimoto J, J. Dermatol., 35, 763–767 (2008).
2) Stout SM and Stumpf JL, Ann. Pharmacother., 44, 1090–1097
(2010).
3) Tsuboi R, Arano O, Nishikawa T, Yamada H, and Katsuoka K,
J. Dermatol., 36, 437–446 (2009).
4) Esfandiari A and Kelly AP, J. Natl. Med. Assoc., 97, 1165–1169
(2005).
5) Kwon OS, Han JH, Yoo HG, Chung JH, Cho KH, Eun HC, and
Kim KH, Phytomedicine, 14, 551–555 (2007).
6) Harada N, Okajima K, Arai M, Kurihara H, and Nakagata N,
Growth Horm. IGF Res., 17, 408–415 (2007).
7) Fujita H and Yamagami T, Phytother. Res., 22, 1275–1281
(2008).
8) Oi Y, Hou IC, Fujita H, and Yazawa K, Phytother. Res., 26,
475–481 (2012).
9) Bo
´
do E,
´
ro
´
T, Telek A, Criger Z, To
´
th BI, Mescalchin A, Ito
T, Bettermann A, Kova
´
cs L, and Paus R, Am. J. Pathol., 166,
985–998 (2005).
10) Obourn JD, Koszewski NJ, and Notides AC, Biochemistry, 32,
6229–6236 (1993).
11) Oh HS and Smart RC, Proc. Natl. Acad. Sci. USA, 93, 12525–
12530 (1996).
12) Hale PA and Ebling FJ, J. Exp. Zool., 191, 49–62 (1975).
13) Thornton MJ, Exp. Dermatol., 11, 187–502 (2002).
14) Ohnemus U, Uenalan M, Inzumza J, Gustafsson JA, and Paus R,
Endocr. Rev., 27, 677–706 (2006).
15) Goodin MG, Fertuck KC, Zacharewski TR, and Rosengren RJ,
Toxicol. Sci., 69, 354–361 (2002).
B
A
Fig. 1. Effects of CBTE and Capsaicin on Hair Growth.
Dorsal hair of 6-week old C3H/He mice, approximately 25 g in
body weight, was removed using an electric clipper and shavers after
anesthetization by intraperitoneal injection of thiopental sodium
(60 mg/kg BW). The mice were treated with a topical application of
3.5% CBTE and 0.05% capsaicin for 14 d (150
mL), and the skin on
the back was then photographed (A). The ratio of the hair growth
area of mice (B) was calculated by the following formula: haired
area shaved area. Data were expressed as the mean SD (n ¼ 8).
p < 0:05 vs. control.

p < 0:01 vs. control.
Hair Growth Promotion by Chinese Black Tea 1607
... The dorsal skin hairs of mice were shaved completely using an electric clipper and a hair waxing cream containing 80% thioglycolic acid (NiClean TM , Ildong Pharmaceutical Co., Seoul, Korea) for inducing anagen synchronization, as described elsewhere [28][29][30]. The next day, a total of 48 mice was divided into eight groups (n = 6 per group) based on their body weights; a control group with DW as a vehicle (DW), six treatment groups with fRGM (fRGM400, fRGM200 and fRGM100) or PH (PH400, PH200 and PH100) at three different doses of 400, 200 and 100 mg/kg in DW. ...
... The dorsal skin image was obtained using a digital camera, and hair growth was assessed as darkening of the dorsal skin, as described previously [28,29]. After treatments for 2 weeks, mice were euthanized using CO2 gas, and the dorsal skin area was sampled. ...
... Hair growth was rapidly increased from day 9 after hair removal and waxing, similar with other studies [28][29][30]. The kinetic hair growth on each day was not significantly different among the groups, probably due to small sample sizes or limitation of the measurements to detect the subtle changes on each day. ...
Article
Full-text available
An abnormal hair-growth cycle induces hair loss, which affects psychological distress and impairs life quality. Red ginseng marc (RGM) is usually discarded as a byproduct after extracting red ginseng, but several studies have shown that the RGM still has bioactive components including ginsenosides. Therefore, the hair-growth effects of fermented RGM (fRGM) and traditional polyherb formula (PH) were examined in C57BL/6 mice. The dorsal hairs of mice were depilated, and they were topically treated with fRGM or PH at 400, 200 and 100 mg/kg or the combination of both middle doses (combi) once a day for two weeks. The hair-covering regions were significantly increased with higher doses of fRGM and PH and in combi groups, compared with the control treated with distilled water. Hair length, thickness and weight also increased in the treatment groups. In particular, the fRGM and PH increased the anagen-phased hair follicles, the follicular diameters and the dermal thickness. Immunostains for Ki-67 showed the anagen-phased cell division in the treatment groups. The beneficial effects were greater in the high doses of fRGM and PH and the combi groups. These suggest hair-growth-promoting effects of fRGM, PH and the combination by enhancing the hair-growth cycle.
... Other are antioxidants which can act against microinflammation (grape seed) or actively inhibits 5α-reductase (green tea [95], ginkgo biloba [94], gingenoside ro [93] or curcumin [96]). Other tea extracts such as Chinese black tea has shown a higher affinity to estrogen receptors promoting also a hair growth enhancer effect [97]. ...
Article
Full-text available
Androgenetic alopecia (AGA) is the most prevalent type of hair loss. Its morbility is mainly psychological although an increased incidence in melanoma has also been observed in affected subjects. Current drug based therapies and physical treatments are either unsuccessful in the long term or have relevant side effects that limit their application. Therefore, a new therapeutic approach is needed to promote regenerative enhancement alternatives. These treatment options, focused on the cellular niche restoration, could be the solution to the impact of dihydrotestosterone in the hair follicle microenvironment. In this context emerging regenerative therapies such as Platelet-rich plasma or Platelet-rich fibrine as well as hair follicle stem cells and mesenchymal stem cell based therapies and their derivatives (conditioned medium CM or exoxomes) are highlighting in the evolving landscape of hair restoration. Nanotechnology is also leading the way in AGA treatment through the design of bioinks and nanobiomaterials whose structures are being configuring in a huge range of cases by means of 3D bioprinting. Due to the increasing number and the rapid creation of new advanced therapies alternatives in the AGA field, an extended review of the current state of art is needed. In addition this review provides a general insight in current and emerging AGA therapies which is intented to be a guidance for researchers highlighting the cutting edge treatments which are recently gaining ground.
... It has been reported that caffeine inhibits phosphodiesterase, that in turn encourages cell proliferation in the hair matrix by increasing the level of cAMP in the cell and thus stimulate its metabolism, this would impede the negative effect of dihydrotestosterone DHT on hair follicle and promotes the elongation of hair fiber (Bansal, Manchanda, and Pandey 2012;Fischer, Hipler, and Elsner 2007). Moreover, flavanoids of black tea such as EGCG have high affinity for estrogen alpha receptor and consequently they possess hair growth promoting activity (Hou et al. 2013). ...
Article
Full-text available
Consuming functional foods and drinks such as kombucha tea is believed to give many beneficial effects for promoting immunity and preventing cancer. The fermented tea with sugar and symbiotic culture of yeast and bacteria is also useful in the topical application for hair re-growth. This study aims to investigate hair re-growth properties of kombucha black tea and chamomile with and without methylsulfonylmethane. Treatments were applied topically to denuded Balb/c mice and observed for hair growth initiation time, density and length in 15 and 30 days in addition to microbiological identification of the main yeast and bacteria. Results showed significantly better hair density and length in groups treated with kombucha black tea with and without MSM, followed by kombucha chamomile tea with and without MSM respectively. In addition, it has been found that MSM promotes hair growth significantly when combined with kombucha ferments. Microbiological analysis indicated the presence of Zygosaccharomyces bailii and Acetobacter genus in the tea broth. Black tea kombucha with MSM can be used as a natural alternative therapy for hair fall and a cost-effective treatment with fewer side effects compared to the synthetic drugs.
Article
Alopecia is a common dermatological disorder of patchy hair loss with substantial patient burden. Phytotherapeutic compounds are increasingly used as a source of new therapeutic options. This review aimed to synthesize the evidence on plant species in hair growth and the methodological aspects of in vivo experimental models. The systematic scoping review was conducted following the PRISMA checklist, Joanna Briggs Institute and in accordance with Cochrane. A systematic search was carried out in the Pubmed, Scopus, Web of Science, and SciELO databases. In vivo experiments that evaluated hair growth activity using natural substances of plant origin were included. Data collection and analysis: A total of 1,250 studies were identified, of which 175 were included for qualitative synthesis. Of these, 128 used mice, 37 rats, 10 rabbits, 1 guinea pig, and 1 sheep as animal models. The methodologies mapped were: hair growth analysis, histological analysis, immunohistochemistry, gene expression analysis, Western blot, enzyme-linked immunosorbent assay, and biochemical analysis. Minoxidil and finasteride were the most commonly used positive controls. The studies evaluated plant species (166), algae (11) or isolated substances (31). Overall 152 plant species and 37 isolated substances were identified. This is the first systematic scoping review on methodological aspects of in vivo hair growth activity. We created a checklist to be completed by authors to allow data comparison and reproducibility, facilitate data interpretation by readers and ensure better quality of evidence. This work may become a valuable tool for future research and contribute to significant advances in hair growth studies.
Article
Full-text available
This narrative review aims to examine the therapeutic potential and mechanism of action of plant extracts in preventing and treating alopecia (baldness). We searched and selected research papers on plant extracts related to hair loss, hair growth, or hair regrowth, and comprehensively compared the therapeutic efficacies, phytochemical components, and modulatory targets of plant extracts. These studies showed that various plant extracts increased the survival and proliferation of dermal papilla cells in vitro, enhanced cell proliferation and hair growth in hair follicles ex vivo, and promoted hair growth or regrowth in animal models in vivo. The hair growth-promoting efficacy of several plant extracts was verified in clinical trials. Some phenolic compounds, terpenes and terpenoids, sulfur-containing compounds, and fatty acids were identified as active compounds contained in plant extracts. The pharmacological effects of plant extracts and their active compounds were associated with the promotion of cell survival, cell proliferation, or cell cycle progression, and the upregulation of several growth factors, such as IGF-1, VEGF, HGF, and KGF (FGF-7), leading to the induction and extension of the anagen phase in the hair cycle. Those effects were also associated with the alleviation of oxidative stress, inflammatory response, cellular senescence, or apoptosis, and the downregulation of male hormones and their receptors, preventing the entry into the telogen phase in the hair cycle. Several active plant extracts and phytochemicals stimulated the signaling pathways mediated by protein kinase B (PKB, also called AKT), extracellular signal-regulated kinases (ERK), Wingless and Int-1 (WNT), or sonic hedgehog (SHH), while suppressing other cell signaling pathways mediated by transforming growth factor (TGF)-β or bone morphogenetic protein (BMP). Thus, well-selected plant extracts and their active compounds can have beneficial effects on hair health. It is proposed that the discovery of phytochemicals targeting the aforementioned cellular events and cell signaling pathways will facilitate the development of new targeted therapies for alopecia.
Article
Although environmental estrogens, including phytoestrogens, play important biological roles, their mechanisms of action are often not explored due to the lack of appropriate biological tools. For example, while capsaicin has been shown to exhibit various biological activities, its association with estrogenic cell signaling is mostly not well understood. We used an oligodeoxynucleotide-based DNA microarray containing estrogen-responsive genes to examine the gene expression profiles of capsaicinoids (capsaicin, dihydrocapsaicin, nordihydrocapsaicin and nonivamide) in human breast cancer MCF-7 cells to understand estrogenic signaling pathways at the transcription level, which was followed by Western blot analysis for signaling pathways at the protein level. While these capsaicinoids lacked cell-proliferation activity in MCF-7 cells, they showed expression profiles with high or moderate correlations (correlation coefficient or to 0.83) with that of 17 -estradiol ( ). Capsaicin seems to regulate the activation of Erk1/2 and PI3K/Akt through the pathways associated with both the epidermal growth factor receptor (EGFR) and the capsaicin receptor (TRPV1). In addition, capsaicin and differed in the regulation of cell cycle-related factors, such as cyclin D1 and p27 . These results indicate that, while these capsaicinoids have estrogenic activity and are functionally similar to , at both the transcriptional and protein levels, they lack the signaling for cell proliferation, and thus belong to silent estrogens, a class of estrogenic chemicals without cell-proliferation activity.
Article
The vanilloid receptor-1 (VR1, or transient receptor potential vanilloid-1 receptor, TRPV1) is activated by capsaicin, the key ingredient of hot peppers. TRPV1 was originally described on sensory neurons as a central integrator of various nociceptive stimuli. However, several human skin cell populations are also now recognized to express TRPV1, but with unknown function. Exploiting the human hair follicle (HF) as a prototypic epithelial-mesenchymal interaction system, we have characterized the HF expression of TRPV1 in situ and have examined TRPV1 signaling in organ-cultured human scalp HF and outer root sheath (ORS) keratinocytes in vitro. TRPV1 immunoreactivity was confined to distinct epithelial compartments of the human HF, mainly to the ORS and hair matrix. In organ culture, TRPV1 activation by capsaicin resulted in a dose-dependent and TRPV1-specific inhibition of hair shaft elongation, suppression of proliferation, induction of apoptosis, premature HF regression (catagen), and up-regulation of intrafollicular transforming growth factor-beta(2). Cultured human ORS keratinocytes also expressed functional TRPV1, whose stimulation inhibited proliferation, induced apoptosis, elevated intracellular calcium concentration, up-regulated known endogenous hair growth inhibitors (interleukin-1beta, transforming growth factor-beta(2)), and down-regulated known hair growth promoters (hepatocyte growth factor, insulin-like growth factor-I, stem cell factor). These findings strongly support TRPV1 as a significant novel player in human hair growth control, underscore the physiological importance of TRPV1 in human skin beyond nociception, and identify TRPV1 as a promising, novel target for pharmacological manipulations of epithelial growth disorders.
Article
We have investigated the hormone- and DNA-binding mechanisms of the wild-type human estrogen receptor (hER) overproduced in insect cells using a baculovirus expression system. The recombinant hER was indistinguishable in size (67 kDa) and immunogenically from the native human estrogen receptor in MCF-7 breast carcinoma cells. The recombinant hER was purified to 70-80% homogeniety with a two-step procedure that included ammonium sulfate precipitation and oligonucleotide affinity chromatography using a unique Teflon affinity matrix. The recombinant hER bound estradiol with a positively cooperative mechanism. At hER concentrations in excess of 13 nM the Hill cofficient reached a maximal value of 1.6, whereas, at lower hER concentrations, the Hill cofficient approached 1.0, suggesting that the hER was dissociated to the monomeric species and site-site interactions were diminished. The hER specifically bound an estrogen responsive element (ERE) from chicken vitellogenin II gene as measured by the gel mobility assay, ethylation, and thymine interference footprinting. Specific interference patterns suggest a two-fold symmetry of the hER binding to the ERE with each monomer of the hER bound in the major groove of the DNA. These data indicate that the recombinant hER is valuable to define the biochemical and structural properties of the native estrogen receptor.
Article
The antiobesity effects of Chinese black tea (Pu-erh tea) and of gallic acid (GA) were investigated using in vitro and in vivo assays. Chinese black tea extract (BTE) and GA inhibited pancreatic lipase activity in a dose-dependent manner in vitro; the IC(inhibitory concentration)(50) values were 101.6 and 9.2 µg/mL, respectively. Black tea extract (50, 100 mg/kg body weight (b.w.)) and GA (15, 45 mg/kg b.w.) significantly suppressed the elevation of blood triglyceride after oral administration of a corn oil emulsion (8 mL oil/kg b.w.) to male ddY mice. Moreover, the antiobesity effects of BTE and GA were also evaluated in a mouse model of diet-induced obesity. Female ddY mice were divided into seven groups; normal diet (ND) group, high fat diet (HFD) group, BTE (0.2% and 0.6% of diets) groups, and GA (0.007%, 0.02% and 0.1% of diets) groups; the experimental groups were fed the test diets for 12 weeks. The BTE 0.6% and GA 0.1% groups showed significant suppression of weight gain. The weight of parametrial adipose tissue was strongly correlated with the body weight. These results suggest that GA contributes to the antiobesity effect of BTE as an active constituent by inhibiting pancreatic lipase activity.
Article
To review available evidence on the safety and efficacy of finasteride in the treatment of alopecia in women. A literature search was conducted through PubMed (1948-March 2010) and MEDLINE (1950-March 2010) using the search terms finasteride and alopecia. References cited in relevant publications were reviewed. All data sources identified were reviewed for inclusion. Reports of finasteride treatment of female alopecia were included in the review. This included prospective and retrospective trials, case series, and case reports. Studies in men were not included. Few pharmacologic options exist for women with alopecia who do not achieve satisfactory responses to topical minoxidil solution. Treatment successes with finasteride in women with female pattern hair loss, although an off-label indication, have been primarily described in uncontrolled studies and anecdotal reports. In 2 controlled clinical studies, finasteride showed no benefit over placebo or no treatment in female pattern hair loss. A finasteride regimen of 1 mg orally daily, as indicated in male pattern hair loss, may be recommended for those who fail or cannot tolerate minoxidil therapy. A 12-month trial is needed to assess stabilization of hair loss, and hair regrowth may take 2 years or longer. Although data are sparse, menopausal status, circulating androgen concentrations, and concomitant symptoms of hyperandrogenism do not appear to predict response to finasteride. Overall, finasteride is well tolerated; however, women of childbearing potential must adhere to reliable contraception while receiving finasteride, and treatment is contraindicated in pregnancy, due to known teratogenicity. Although objective evidence of efficacy is limited, finasteride may be considered for treatment of female pattern hair loss in patients who fail topical minoxidil treatment.
Article
Minoxidil is efficacious in inducing hair growth in patients with androgenetic alopecia by inducing hair follicles to undergo transition from the early to late anagen phase. Although the efficacy of 1% topical minoxidil has been confirmed in Japan, no controlled study of 5% topical minoxidil has been conducted using male Japanese subjects. The objective of this trial was to verify the superiority in clinical efficacy of 5% topical minoxidil to 1% topical minoxidil in a double-blind controlled study with male, Japanese androgenetic alopecia patients as the subjects. The trial included 300 Japanese male patients aged 20 years or older with androgenetic alopecia who were administered either 5% topical minoxidil (n = 150) or 1% topical minoxidil (n = 150) for 24 weeks. The mean change from the baseline in non-vellus hair/cm(2), the primary efficacy variable, was 26.4 (n = 142) in the 5% topical minoxidil group and 21.2 (n = 144) in the 1% topical minoxidil group at 16 weeks, the main time point for the evaluation. The difference between the groups was significant (P = 0.020). The incidence of adverse events was 8.7% (13/150) in the 5% group and 5.3% (8/150) in the 1% group, with no significant difference between the groups (chi(2)-test: P = 0.258). Our findings confirmed the superiority of 5% topical minoxidil to 1% topical minoxidil in treating Japanese men with androgenetic alopecia.
Article
Adenosine upregulates the expression of vascular endothelial growth factor and fibroblast growth factor-7 in cultured dermal papilla cells. It has been shown that, in Japanese men, adenosine improves androgenetic alopecia due to the thickening of thin hair due to hair follicle miniaturization. To investigate the efficacy and safety of adenosine treatment to improve hair loss in women, 30 Japanese women with female pattern hair loss were recruited for this double-blind, randomized, placebo-controlled study. Volunteers used either 0.75% adenosine lotion or a placebo lotion topically twice daily for 12 months. Efficacy was evaluated by dermatologists and by investigators and in phototrichograms. As a result, adenosine was significantly superior to the placebo according to assessments by dermatologists and investigators and by self-assessments. Adenosine significantly increased the anagen hair growth rate and the thick hair rate. No side-effects were encountered during the trial. Adenosine improved hair loss in Japanese women by stimulating hair growth and by thickening hair shafts. Adenosine is useful for treating female pattern hair loss in women as well as androgenetic alopecia in men.
Article
The growth of hair from epilated and non-epilated areas of rats receiving a variety of hormonal treatments was investigated by pulse-labelling with 35S-cystine. While epilation at certain stages of the spontaneous cycle may rephase follicular activity, it did not affect the length, rate or duration of growth of the hairs which erupted subsequently, either in untreated or hormone-treated rats. Thyroxine shortened the active as well as the resting phase of the follicular cycle. It also increased the growth rate, so that hairs were ultimately the same length as those from untreated animals. Estradiol slightly shortened the duration of the active phase, even though the complete cycle was prolonged. It also decreased the hair growth rate. When administered simultaneously, estradiol and thyroxine exerted their effects independently.
Article
We have investigated the hormone- and DNA-binding mechanisms of the wild-type human estrogen receptor (hER) overproduced in insect cells using a baculovirus expression system. The recombinant hER was indistinguishable in size (67 kDa) and immunogenically from the native human estrogen receptor in MCF-7 breast carcinoma cells. The recombinant hER was purified to 70-80% homogeneity with a two-step procedure that included ammonium sulfate precipitation and oligonucleotide affinity chromatography using a unique Teflon affinity matrix. The recombinant hER bound estradiol with a positively cooperative mechanism. At hER concentrations in excess of 13 nM the Hill coefficient reached a maximal value of 1.6, whereas, at lower hER concentrations, the Hill coefficient approached 1.0, suggesting that the hER was dissociated to the monomeric species and site-site interactions were diminished. The hER specifically bound an estrogen responsive element (ERE) from chicken vitellogenin II gene as measured by the gel mobility assay, ethylation, and thymine interference footprinting. Specific interference patterns suggest a two-fold symmetry of the hER binding to the ERE with each monomer of the hER bound in the major groove of the DNA. These data indicate that the recombinant hER is valuable to define the biochemical and structural properties of the native estrogen receptor.
Article
The hair follicle is a cyclic, self renewing epidermal structure which is thought to be controlled by signals from the dermal papilla, a specialized cluster of mesenchymal cells within the dermis. Topical treatments with 17-beta-estradiol to the clipped dorsal skin of mice arrested hair follicles in telogen and produced a profound and prolonged inhibition of hair growth while treatment with the biologically inactive stereoisomer, 17-alpha-estradiol, did not inhibit hair growth. Topical treatments with ICI 182,780, a pure estrogen receptor antagonist, caused the hair follicles to exit telogen and enter anagen, thereby initiating hair growth. Immunohistochemical staining for the estrogen receptor in skin revealed intense and specific staining of the nuclei of the cells of the dermal papilla. The expression of the estrogen receptor in the dermal papilla was hair cycle-dependent with the highest levels of expression associated with the telogen follicle. 17-beta-Estradiol-treated epidermis demonstrated a similar number of 5-bromo-2'-deoxyuridine (BrdUrd) S-phase cells as the control epidermis above telogen follicles; however, the number of BrdUrd S-phase basal cells in the control epidermis varied according to the phase of the cycle of the underlying hair follicles and ranged from 2.6% above telogen follicles to 7.0% above early anagen follicles. These findings indicate an estrogen receptor pathway within the dermal papilla regulates the telogen-anagen follicle transition and suggest that diffusible factors associated with the anagen follicle influence cell proliferation in the epidermis.
Article
Recent investigations have demonstrated that polyphenolic catechins inhibit breast cancer cell proliferation and tumor growth. However, the ER-mediated effects of the three predominant catechins (EGCG, ECG, and EGC) have not been extensively examined in vitro or in vivo. Therefore, EGCG, ECG, and EGC were examined for their ability to compete with [(3)H]-17beta-estradiol ([(3)H]-E(2)) for binding to ERalpha and ERbeta and to elicit reporter gene activity in MCF-7 human breast cancer cells transiently transfected with either chimeric ERalpha or ERbeta. EGCG and ECG displaced [(3)H]-E(2) from GST-hERalphadef (D, E, and F domains of human ERalpha fused to GST) or from full-length human ERbeta. Additionally, only EGCG elicited Gal4-hERalphadef and Gal4-mERbetadef-mediated reporter gene expression (EC(50) values: 28 and 19 micro M, respectively) in MCF-7 cells cotransfected with a Gal4-regulated luciferase reporter gene. In cotreatment experiments, EGCG (1-50 micro M) and ECG (1 micro M) decreased E(2)-induced (1 nM) ERbeta-mediated gene expression 35-50%. In vivo, no catechin induced estrogenic responses (uterine weight or uterine peroxidase activity) in immature C57BL/6 mice. However, when mice were cotreated with E(2) (10 micro g/kg/day, 3 days) and either EGCG (30 and 50 mg/kg/day, 3 days) or ECG (50 mg/kg/day, 3 days), uterine peroxidase activity was increased 2.3-fold above that elicited by E(2) alone. In conclusion, EGCG and ECG bind to ERalpha and ERbeta, but only EGCG elicited ER-mediated gene expression in vitro. However, both of these compounds moderately increased E(2)-inducible responses in vivo.